Lv51
850 积分 2023-03-03 加入
Development of a novel humanized anti-TSLP monoclonal antibody, QX008N, and exploration of combination therapy of anti-TSLP antibody and anti-IL-4R antibody
8小时前
已完结
Opportunities and limitations of B cell depletion approaches in SLE
6天前
已完结
Proximity between LAG-3 and the T cell receptor guides suppression of T cell activation and autoimmunity
11天前
已完结
The immunology of asthma
13天前
已完结
Trigeminal ganglion neurons are directly activated by influx of CSF solutes in a migraine model
14天前
已完结
Pharmacologic Characterization of ALD1910, a Potent Humanized Monoclonal Antibody against the Pituitary Adenylate Cyclase-Activating Peptide
14天前
已完结
Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
21天前
已完结
Patient Outcomes and Safety of Combination Biologic Therapy with Dupilumab: A Systematic Review
21天前
已关闭
The global burden of inflammatory bowel disease: from 2025 to 2045
28天前
已完结
Synergistic relationship between TSLP and IL‐33/ST2 signaling pathways in allergic rhinitis and the effects of hypoxia
1个月前
已完结
皖公网安备34019202002308
